Michael Ross

Michael Ross

Direktor/Vorstandsmitglied bei
Adimab LLC
77 Jahre
Health Technology
Commercial Services
Consumer Services

Profil

Michael Jay Ross was the founder of CyThera, Inc. (1999), serving as Chief Executive Officer & Director; Arris Pharmaceutical Corp.
(1990), serving as Chief Executive Officer & Director; Metaxen LLC (1996), serving as Chief Executive Officer & Director; ExSAR Corp.
(1999), serving as Chief Executive Officer.
Dr. Ross is currently a Director at Adimab LLC, PanOptica, Inc., Rempex Pharmaceuticals, Inc., Thayer School of Engineering At Dartmouth, Pionyr Immunotherapeutics, Inc., Ribometrix, Inc., Cellinta Ltd. (since 2020), TRex Bio Ltd. (since 2020), Xilio Therapeutics LLC (since 2020), and a Senior Partner at SV Health Investors LLC.
Former positions include Chief Executive Officer at Cythera Pharmaceuticals, Inc.; Chairman at Ikano Therapeutics, Inc.; Co-Chairman at Astria Therapeutics, Inc. (2010-2019); Director at Xenova Group Plc, Epimmune, Inc., Genencor International, Inc., ADERIS Pharmaceuticals, Inc., Archemix Corp., Link Medicine Corp., Alinea Pharmaceuticals, Inc., Sutro Biopharma, Inc., Itero Biopharmaceuticals, Inc., Thesan Pharmaceuticals, Inc., GlycoFi, Inc., Rinat Neuroscience Corp., MPEX Pharmaceuticals, Inc., Juvaris BioTherapeutics, Inc.; Independent Director at Arsanis, Inc. (2011-2019), IVERIC bio, Inc. (2013-2019), Xilio Therapeutics, Inc. (2020-2023), and Deciphera Pharmaceuticals, Inc. (2015-2019); Vice President-Development at Genentech, Inc. (1978-1990); Managing Partner at Didyma LLC (1999-2002).
Education includes an undergraduate degree from Dartmouth College, a doctorate from Harvard University, and a doctorate from California Institute of Technology.

Aktive Positionen von Michael Ross

UnternehmenPositionBeginn
Private Equity Investor 01.01.2001
Direktor/Vorstandsmitglied -
Direktor/Vorstandsmitglied -
Direktor/Vorstandsmitglied -
Direktor/Vorstandsmitglied -
Direktor/Vorstandsmitglied -
Direktor/Vorstandsmitglied -
Direktor/Vorstandsmitglied 10.03.2020
Direktor/Vorstandsmitglied 12.01.2020
░░░░░ ░░░░░░░░░░░░ ░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░

Ehemalige bekannte Positionen von Michael Ross

UnternehmenPositionEnde
░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░
Sehen Sie sich die Erfahrung von Michael Ross im Detail an

Ausbildung von Michael Ross

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

80

Beziehungen ersten Grades

45

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen45

Health Technology

Commercial Services

Health Technology

Health Technology

Finance

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Technology Services

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Commercial Services

Commercial Services

Health Technology

Finance

Consumer Services

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Didyma LLC

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Cythera Pharmaceuticals, Inc.

Finance

Health Technology

Health Technology

  1. Börse
  2. Insiders
  3. Michael Ross
-40 %: Die besten Tools exklusiv für Abonnenten - Ihr Schlüssel zu den Top-Investitionen der Zukunft!
T
:
:
PROFITIEREN SIE JETZT